selected publications
-
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.
The Journal of antimicrobial chemotherapy.
2015
Academic Article
GET IT
Times cited: 149 -
Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia.
Antimicrobial agents and chemotherapy.
2014
Academic Article
GET IT
Times cited: 101 -
Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies.
Leukemia & lymphoma.
2012
Academic Article
GET IT
Times cited: 86 -
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
The New England journal of medicine.
2007
Academic Article
GET IT
Times cited: 1292 -
Role and effect of TNF-alpha in experimental visceral leishmaniasis.
Journal of immunology (Baltimore, Md. : 1950).
1994
Academic Article
GET IT
Times cited: 117 -
Human immunodeficiency virus infection and bacteremic meningococcal pneumonia.
The Journal of infectious diseases.
1991
Article
GET IT
Times cited: 9